Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02008305
Other study ID # SC/DM_MPN_2012-4
Secondary ID
Status Terminated
Phase N/A
First received December 3, 2013
Last updated February 8, 2017
Start date November 2013
Est. completion date November 2016

Study information

Verified date February 2017
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Interventional Neuroradiology replaces surgery. This technology requires various exposition to X rays : number of X rays photographs, radioscopy, distance between patient and detector, speed of acquisition of X-rays photographs, high tension and intensity.

The manipulator must find the right balance between quality of photographs and dose delivered to the patient (optimization).

Children are particularly exposed to these risks of irradiation (sensitivity to X-rays and long life expectancy with risks. So, it is fundamental to optimize the dose delivered during the procedures.

The investigators propose to analyse a study comparing two protocols of optimization of doses. The investigators' hypothesis is that the protocol experimented in this trial allows less radiation of the children, compared to the usual protocol.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date November 2016
Est. primary completion date November 2016
Accepts healthy volunteers No
Gender All
Age group N/A to 14 Years
Eligibility Inclusion Criteria:

- malformation or occlusion of a cerebral vessel requiring interventional Neuroradiology

Exclusion Criteria:

- opposition ot the parent(s) to the participation of their child in the trial and/or no social security.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
protocol of optimization ALARA

protocol of optimization Philips


Locations

Country Name City State
France Fondation ophtalmique Adolphe de Rothschild Paris

Sponsors (1)

Lead Sponsor Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other number of interrupted dosing one day per patient
Primary Comparison of the average dose per child, according to the protocol maximum one day per patient
Secondary number of X-rays photographs according to the protocol, quality of photographs according to the protocol, maximum one day per patient